Galaxy Diagnostics, Inc.
PrivateLast Round
Strategic
Jun 3, 2026
Total Funding Raised
$2.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Galaxy Diagnostics, Inc. is a biotechnology company that develops and provides advanced diagnostic tests for detecting vector-borne pathogens, such as those causing Bartonellosis and Lyme disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galaxy Diagnostics, Inc. Comparables
Compare Galaxy Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IGeneX | 85% | |
| T Lab Inc. | 83% | |
| ArminLabs | 81% |
Galaxy Diagnostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 3, 2026 | ||||
| Debt | Jul 10, 2024 | ||||
| VC Round | Jan 14, 2015 | ||||
| VC Round | Sep 4, 2013 | ||||
| Debt | Mar 5, 2013 | ||||
VC Round | May 1, 2012 |
Galaxy Diagnostics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Triangle Tweener Fund | Debt, Strategic |
| Ariel Savannah Angel Partners | Strategic |
| North Carolina Biotechnology Center | Debt |
| Center for Entrepreneurial Development | Strategic |
| Boston Harbor Angels | Debt, Strategic |
| Wisconsin Investment Partners | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
Raised $3M in a Seed Round.
- May 18, 2026
Monthly visitors increased 78% MoM, reaching 7.8K.
Galaxy Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Galaxy Diagnostics, Inc.'s valuation, stock price, and market status.
Is Galaxy Diagnostics, Inc. a public or private company?
Galaxy Diagnostics, Inc. is a private company.
What is the current stock price of Galaxy Diagnostics, Inc.?
Galaxy Diagnostics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Galaxy Diagnostics, Inc. worth (valuation)?
Valuation information for Galaxy Diagnostics, Inc. is not publicly available.
Can I buy Galaxy Diagnostics, Inc. stock?
Galaxy Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Galaxy Diagnostics, Inc.'s last funding round?
Galaxy Diagnostics, Inc.'s most recent funding round was Seed Round on June 3, 2026.
Who are the main investors in Galaxy Diagnostics, Inc.?
Key investors in Galaxy Diagnostics, Inc. include Triangle Tweener Fund, Ariel Savannah Angel Partners, Center for Entrepreneurial Development, Boston Harbor Angels, Wisconsin Investment Partners.
Will Galaxy Diagnostics, Inc. IPO soon?
No public IPO plans have been announced for Galaxy Diagnostics, Inc..
How can I track Galaxy Diagnostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galaxy Diagnostics, Inc.'s secondary market activity and sign up for updates.